Results 211 to 220 of about 133,249 (261)
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
JAMA OncolSzlosarek PW, Creelan BC, Sarkodie T, Nolan L, Taylor P, Olevsky O, Grosso F, Cortinovis D, Chitnis M, Roy A, Gilligan D, Kindler H, Papadatos-Pastos D, Ceresoli GL, Mansfield AS, Tsao A, O'Byrne KJ, Nowak AK, Steele J, Sheaff M, Shiu CF, Kuo CL, Johnston A, Bomalaski J, Zauderer MG, Fennell DA, ATOMIC-Meso Study Group. +26 moreeuropepmc +1 more sourceProspective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. [PDF]
Nat CancerBiswas D, Liu YH, Herrero J, Wu Y, Moore DA, Karasaki T, Grigoriadis K, Lu WT, Veeriah S, Naceur-Lombardelli C, Magno N, Ward S, Frankell AM, Hill MS, Colliver E, de Carné Trécesson S, East P, Malhi A, Snell DM, O'Neill O, Leonce D, Mattsson J, Lindberg A, Micke P, Moldvay J, Megyesfalvi Z, Dome B, Fillinger J, Nicod J, Downward J, Szallasi Z, TRACERx Consortium, Hackshaw A, Jamal-Hanjani M, Kanu N, Birkbak NJ, Swanton C. +36 moreeuropepmc +1 more sourceRepresentation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. [PDF]
Nat CommunHynds RE, Huebner A, Pearce DR, Hill MS, Akarca AU, Moore DA, Ward S, Gowers KHC, Karasaki T, Al Bakir M, Wilson GA, Pich O, Martínez-Ruiz C, Hossain ASMM, Pearce SP, Sivakumar M, Ben Aissa A, Grönroos E, Chandrasekharan D, Kolluri KK, Towns R, Wang K, Cook DE, Bosshard-Carter L, Naceur-Lombardelli C, Rowan AJ, Veeriah S, Litchfield K, Crosbie PAJ, Dive C, Quezada SA, Janes SM, Jamal-Hanjani M, Marafioti T, TRACERx consortium, McGranahan N, Swanton C. +36 moreeuropepmc +1 more sourcePrioridades de conservación y desarrollo en las comunidades de Nor Yauyos: Informe para el MRSEH de la cuenca del río Cañete [PDF]
, 2016 Blundo Canto, Genowefa M., Cruz García, Gisella S., Pareja Cabrejos, Piedad, Quintero, Marcela, Tristán Febres, María Claudia +4 morecore Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer. [PDF]
J Clin OncolYang JC, Lee DH, Lee JS, Fan Y, de Marinis F, Iwama E, Inoue T, Rodríguez-Cid J, Zhang L, Yang CT, de la Mora Jimenez E, Zhou J, Pérol M, Lee KH, Vicente D, Ichihara E, Riely GJ, Luo Y, Chirovsky D, Pietanza MC, Bhagwati N, Lu S. +21 moreeuropepmc +1 more source
